Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Oxygen and Hospira sign development and commercial supply agreement for Oxycyte

April 15, 2009

BioSante launches Elestrin in the U.S.

April 15, 2009

Novel compounds for the treatment of diabetes discovered by Kyorin and ActivX

April 15, 2009

Statin dose effect on HDL-cholesterol not uniform across agents

April 14, 2009

Array BioPharma initiates clinical trial for ARRY-403 in type 2 diabetes

April 9, 2009

Cardiovascular risk with PPAR agonist aleglitazar assessed in diabetes patients

April 8, 2009

Exenatide induces weight loss and glucose normalization in nondiabetic obese patients

April 8, 2009

Patient achieves insulin independence with Diabecell in phase I/IIa trial

April 7, 2009

Japanese launch for Recalbon/Bonoteo Tablets

April 7, 2009

KS-C370G shows cardioprotective activity in rat model of type 1 diabetes

April 7, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...